No Data
Strong performance, with an upward trend in the Dow Inc average leading to dominance in buying on dips.
[Emerging Markets Individual Stocks Global Strategy] Today's Emerging Markets are expected to show a stable development. On March 31, the US Stocks market saw the Dow Inc rise by 417.86 points (+1.00%) to 42,001.76, rebounding for the first time in four days. Caution over Trump's tariffs and the diminishing expectations of a ceasefire between Russia and Ukraine weighed on stock prices. On the other hand, the unexpected rise in the Chicago Purchasing Managers' Index and the month-end and quarter-end 'dressing buys' supported the market. Today's Emerging Markets are favorable for Buy.
Shimamura, operating profit in 25/2 increased by 7.1% to 59.2 billion yen, Financial Estimates for 26/2 increased by 2.4% to 60.6 billion yen.
The performance for the fiscal year ending February 2025 announced by Shimamura <8227> shows that revenue increased by 4.8% compared to the previous period, reaching 665.3 billion 58 million yen, and operating profit increased by 7.1%, amounting to 59.2 billion 40 million yen. In the Shimamura business, with the main private brand "CLOSSHI," products that solve customer anxieties and dissatisfaction, such as the long-lasting series "Hebirote" and the sleep space Resistance series "Minmin Lab," were sold, while enhancing the added value of the high-priced PB.
Perseus Proteomics Releases FY2025 Business Forecasts Amid Licensing Challenges
Perseus Proteomics: Notice regarding earnings forecasts for the fiscal year ending March 31, 2025
Perseus Proteomics Sees FY Parent Pretax Loss Y846.00M
Continuing to rise, attempting to recover against the background of buy on dips, ETC.
Overview of the previous week from March 17 to March 21, Tokyo Stock Exchange Growth Index High: 672.42 Low: 657.81 Close: 667.1 compared to the previous week: 1.19% ↑ continued rise, trying to recover supported by bargain hunting and other factors. It showed a trend of attempting recovery supported by bargain buying. Among individual stocks, a portion of biotech-related stocks such as Perseus Proteomics <4882> and Sanbio <4592> showed movement. However, large Market Cap stocks such as Trial HD <141A> and Integral <5842>.